Clinical characteristics of Kraepelinian schizophrenia: Replication and extension of previous findings

American Journal of Psychiatry

Volumn 153, Issue 6, 1996, Pages 806-811

  Keefe, Richard S E ^a   Frecska, Ede ^b   Apter, Seth H ^b   Davidson, Michael ^b   Macaluso, Joseph M ^b   Hirschowitz, Jack ^b   Davis, Kenneth L ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHLORPROMAZINE; NEUROLEPTIC AGENT;

ADULT; ARTICLE; CLINICAL FEATURE; DEMOGRAPHY; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; RATING SCALE; SCHIZOPHRENIA; SELF CARE;

EID: 0029895435     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/ajp.153.6.806     Document Type: Article

References (30)

1. Fenton WS, McGlashan TH: Natural history of schizophrenia subtypes, I: longitudinal study of paranoid, hebephrenic, and undifferentiated schizophrenia. Arch Gen Psychiatry 1991; 48: 969-977
2. Fenton WS, McGlashan TH: Natural history of schizophrenia subtypes, II: positive and negative symptoms and long-term course. Arch Gen Psychiatry 1991; 48:978-986
3. Andreasen NC (ed): Schizophrenia: Positive and Negative Symptoms and Syndromes: Modern Problems of Pharmacopsychiatry, vol 24. Basel, Switzerland, S Karger, 1990
4. Bleuler E: Dementia Praecox or the Group of Schizophrenias (1911). Translated by Zinkin J. New York, International Universities Press, 1950
5. Strauss JS, Carpenter WT, Bartko JJ: The diagnosis and understanding of schizophrenia, part III: speculations on the processes that underlie schizophrenic symptoms and signs. Schizophr Bull 1974; 11:61-76
6. Crow TJ: Molecular pathology of schizophrenia: more than one disease process? Br Med J 1980; 280:66-68
7. Andreasen NC, Olsen S: Negative v positive schizophrenia: definition and validation. Arch Gen Psychiatry 1982; 39:789-794
8. Harrow M, Carone BJ, Westermeyer JF: The course of psychosis in early phases of schizophrenia. Am J Psychiatry 1985; 142: 702-707
9. Lindenmayer J-P, Kay SR, Friedman C: Negative and positive schizophrenic syndromes after the acute phase: a prospective followup. Compr Psychiatry 1986; 27:276-286
10. Kay SR, Lindenmayer J-P: Outcome predictors in acute schizophrenia: prognostic significance of background and clinical dimensions. J Nerv Ment Dis 1987; 175:152-160
11. Livingston MG, Watt JAG, Greene JG, Kershaw PW, Todd NA, Scott AM, Loudon J, Dyer JAT, Phillip AE, Batchelor D: The Scottish first episode schizophrenia study, VII: two year follow-up. Acta Psychiatr Scand 1989; 80:597-602
12. Kendler KS, Gruenberg AM, Tsuang MT: Subtype stability in schizophrenia. Am J Psychiatry 1985; 142:827-832
13. Keefe RSE, Mohs RC, Losonczy MF, Davidson M, Silverman JM, Kendler KS, Horvath TB, Nora R, Davis KL: Characteristics of very poor outcome schizophrenia. Am J Psychiatry 1987; 144: 889-895
14. Endicott J, Spitzer RL: A diagnostic interview: the Schedule for Affective Disorders and Schizophrenia. Arch Gen Psychiatry 1978; 35:837-844
15. Andreasen NC, Flaum M, Arndt S: The Comprehensive Assessment of Symptoms and History (CASH): an instrument for assessing diagnosis and psychopathology. Arch Gen Psychiatry 1992; 49:615-623
16. Andreasen NC, Olsen S: Negative v positive schizophrenia: definition and validation. Arch Gen Psychiatry 1982; 39:789-794
17. Keefe RSE, Harvey PD, Lenzenweger M, Apter S, Schmeidler J, Mohs RC, Davis KL: Empirical assessment of the factorial structure of clinical symptoms in schizophrenia: negative symptoms. Psychiatry Res 1992; 44:153-165
18. Andreasen NC: Thought, language, and communication disorders, I: clinical assessment, definition of terms, and evaluation of their reliability. Arch Gen Psychiatry 1979; 36:1315-1321
19. Harvey PD, Lenzenweger M, Keefe RSE, Pogge DL, Mohs RC: Empirical assessment of the factorial structure of clinical symptoms in schizophrenia: formal thought disorder. Psychiatry Res 1992; 44:141-152
20. Andreasen NC: Scale for the Assessment of Positive Symptoms (SAPS). Iowa City, University of Iowa, 1984
21. Gittelman-Klein R, Klein DF: Premorbid asocial adjustment and prognosis in schizophrenia. J Psychiatr Res 1969; 7:33-35
22. Small NE, Mohs RC, Halperin R, Rosen WG, Masterson C, Kendler KS, Horvath TB, Davis KL: A study of the reliability of reported premorbid adjustment in schizophrenic patients. Biol Psychiatry 1984; 19:203-211
23. Harvey PD, Putnam KM, Davidson M, Kahn R, Powchick P, McQueeney R, Keefe RSE, Davis KL: Brief neuroleptic discontinuation and clinical symptoms in Kraepelinian and non-Kraepelinian schizophrenia. Psychiatry Res 1991; 38:285-292
24. Cloninger CR, Martin RL, Guze SB, Clayton PJ: Diagnosis and prognosis in schizophrenia. Arch Gen Psychiatry 1985; 42:15-25
25. Kendell RE, Brockington IF: The identification of disease entities and the relationship between schizophrenic and affective psychoses. Br J Psychiatry 1980; 137:324-331
26. Keefe RSE, Mohs RC, Losonczy MF, Davidson M, Silverman JM, Horvath TB, Davis KL: Premorbid sociosexual functioning and long-term outcome in schizophrenia. Am J Psychiatry 1989; 146:206-211
27. Kelley ME, Gilbertson M, Mouton A, van Kammen DP: Deterioration in premorbid functioning in schizophrenia: a developmental model of negative symptoms in drug-free patients. Am J Psychiatry 1992; 149:1543-1548
28. Lewine RRJ, Watt NF, Fryer JH: A study of childhood social competence, adult premorbid competence, and psychiatric outcome in three schizophrenic subtypes. J Abnorm Psychol 1978; 87:294-302
29. McGlashan TH: Predictors of shorter- , medium- , and longer-term outcome in schizophrenia. Am J Psychiatry 1986; 143:50-55
30. Keefe RSE, Blum C, Roitman SL, Harvey PD, Davidson M, Mohs RC, Davis KL: Cognitive dysfunction in Kraepelinian schizophrenics, in Proceedings of the 32nd Annual Meeting of the American College of Neuropsychopharmacology. Nashville, ACN, 1993, p 84